Erythropoietin-induced hypertension.
Ismail
N
N
Vanderbilt University School of Medicine, Nashville, TN, USA.
Ikizler
T A
TA
D000740:Anemia / Q000150:complications; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004921:Erythropoietin / Q000009:adverse effects*; D006439:Hemodynamics; D006801:Humans; D006973:Hypertension / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D008297:Male; D008991:Monitoring, Physiologic; D015337:Multicenter Studies as Topic; D011994:Recombinant Proteins; D006435:Renal Dialysis; D012307:Risk Factors; D014655:Vascular Resistance
D011994:Recombinant Proteins; D004921:Erythropoietin